BioMarin Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Cash & Equivalents	1,250	942.84	755.13	724.53	587.28	649.16	Upgrade
Short-Term Investments	227.73	194.86	318.68	567.01	426.6	416.23	Upgrade
Cash & Short-Term Investments	1,478	1,138	1,074	1,292	1,014	1,065	Upgrade
Cash Growth	58.83%	5.95%	-16.86%	27.39%	-4.83%	41.33%	Upgrade
Accounts Receivable	790.27	660.54	633.7	461.32	373.4	448.35	Upgrade
Receivables	790.27	660.54	633.7	461.32	373.4	448.35	Upgrade
Inventory	1,382	1,233	1,107	894.08	776.67	698.55	Upgrade
Other Current Assets	204.27	201.53	141.39	104.52	110.44	129.93	Upgrade
Total Current Assets	3,855	3,232	2,956	2,751	2,274	2,342	Upgrade
Property, Plant & Equipment	1,038	1,077	1,112	1,114	1,082	1,090	Upgrade
Long-Term Investments	512.94	527.84	622.44	370.34	524.29	295.97	Upgrade
Goodwill	196.2	196.2	196.2	196.2	196.2	196.2	Upgrade
Other Intangible Assets	233.11	327.38	325.3	338.57	388.65	417.27	Upgrade
Long-Term Deferred Tax Assets	1,509	1,489	1,546	1,505	1,450	1,432	Upgrade
Other Long-Term Assets	270.78	138.94	83.56	98.78	89.2	74.63	Upgrade
Total Assets	7,615	6,989	6,842	6,375	6,005	5,848	Upgrade
Accounts Payable	389.67	235.4	315.51	231.24	199.68	191.43	Upgrade
Accrued Expenses	324.75	331.27	311.55	293.53	267.65	257.27	Upgrade
Current Portion of Long-Term Debt	-	-	493.88	-	-	-	Upgrade
Current Portion of Leases	7.58	7.57	8.78	10.38	10.46	11.75	Upgrade
Current Income Taxes Payable	22.61	12.57	2.65	16.21	1.21	9.66	Upgrade
Current Unearned Revenue	-	1.37	4.62	0.71	6.96	0.15	Upgrade
Other Current Liabilities	53.84	18.8	40.04	36.81	60.54	22.29	Upgrade
Total Current Liabilities	798.44	606.99	1,177	588.88	546.5	492.55	Upgrade
Long-Term Debt	596.66	595.14	593.1	1,083	1,079	1,075	Upgrade
Long-Term Leases	-	31.26	38.12	26.51	33.84	44.49	Upgrade
Other Long-Term Liabilities	163.06	97.57	81.81	73.5	79.69	129.84	Upgrade
Total Liabilities	1,558	1,331	1,890	1,772	1,739	1,742	Upgrade
Common Stock	0.19	0.19	0.19	0.19	0.18	0.18	Upgrade
Additional Paid-In Capital	5,901	5,802	5,612	5,405	5,192	4,993	Upgrade
Retained Earnings	200.78	-194.7	-621.55	-789.2	-930.76	-861.61	Upgrade
Comprehensive Income & Other	-45.23	50.43	-38.65	-12.73	4.74	-25.98	Upgrade
Shareholders' Equity	6,057	5,658	4,952	4,603	4,266	4,106	Upgrade
Total Liabilities & Equity	7,615	6,989	6,842	6,375	6,005	5,848	Upgrade
Total Debt	604.24	633.97	1,134	1,120	1,123	1,131	Upgrade
Net Cash (Debt)	873.6	503.74	-60.07	171.63	-109.51	-66	Upgrade
Net Cash Growth	166.54%	-	-	-	-	-	Upgrade
Net Cash Per Share	4.44	2.56	-0.31	0.91	-0.60	-0.34	Upgrade
Filing Date Shares Outstanding	192.11	190.78	188.68	186.53	184.03	181.83	Upgrade
Total Common Shares Outstanding	192.1	190.76	188.6	186.25	183.91	181.74	Upgrade
Working Capital	3,056	2,625	1,779	2,163	1,728	1,850	Upgrade
Book Value Per Share	31.53	29.66	26.25	24.71	23.19	22.59	Upgrade
Tangible Book Value	5,627	5,134	4,430	4,068	3,681	3,493	Upgrade
Tangible Book Value Per Share	29.29	26.92	23.49	21.84	20.01	19.22	Upgrade
Land	-	90.78	90.78	90.79	90.42	90.42	Upgrade
Buildings	-	892.48	860.81	819.1	774.92	761.56	Upgrade
Machinery	-	789.5	796.61	736.25	688.54	644.4	Upgrade
Construction In Progress	-	90.27	100.01	143.38	136.74	109.14	Upgrade
Leasehold Improvements	-	44.37	58.23	59.53	55.28	55.13	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.